Ozempic copies restricted after US judge denies injunction
April 24 (Reuters) - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's (NOVOb.CO), opens new tab popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds, court records show.
The decision came in response to a February lawsuit from a compounding industry group against the U.S. Food and Drug Administration's decision that there was no longer a shortage of the medicines' active ingredient, semaglutide.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Compounders had been allowed to produce hundreds of thousands of doses of copies of Novo's obesity and diabetes drugs only while the FDA said they were in short supply. Many of these are sold by large telehealth companies like Hims & Hers.
U.S. District Judge Mark Pittman in Texas denied compounders' bid for a preliminary injunction, according to the court docket. Pittman filed his legal reasoning under seal, but by denying the injunction request, a May timeline set by the FDA for when large U.S. compounders will have to exit the market remains in place.
It also follows a decision the judge made earlier this year refusing to allow compounding pharmacies to keep making copies of Eli Lilly's (LLY.N), opens new tab weight-loss and diabetes drugs Zepbound and Mounjaro.
The FDA and Novo Nordisk did not immediately respond to requests for comment.
Lee Rosebush, chairman of lead plaintiff Outsourcing Facilities Association, told Reuters that his organization had presented evidence of an ongoing semaglutide shortage that was obtained after the lawsuit was filed. However, Rosebush said the judge declined to consider it, finding that it was filed late.
The FDA had said it would not take any enforcement action against compounders before the court ruled.
The regulator has given larger so-called outsourcing facilities, which make compounded drugs in bulk and are regulated by the agency, until May 22. Smaller compounding pharmacies, which make drugs to fill prescriptions for individual patients and are primarily overseen by U.S. states, must immediately cease making copies of semaglutide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
an hour ago
- Reuters
US wholesale inventories in April revised higher
WASHINGTON, June 9 (Reuters) - U.S. wholesale inventories increased in April amid stockpiling of prescription medication in anticipation of tariffs from the Trump administration. Stocks at wholesalers rose 0.2% instead of being unchanged, as estimated last month, the Commerce Department's Census Bureau said on Monday. Economists polled by Reuters had expected last month's estimate would be unrevised. Inventories, a key part of gross domestic product, climbed 0.3% in March. They advanced 2.3% on a year-over-year basis in April. Wholesale stocks of prescription medication surged 1.3% in April. There were also increases in apparel, motor vehicle, groceries and professional equipment inventories. President Donald Trump has said he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients. Apart from drugmakers, businesses front-loaded imports in the first quarter, seeking to avoid Trump's sweeping duties on foreign goods, resulting in a large trade deficit that subtracted a record 4.90 percentage points from GDP. The front-running faded in April, leading to a record decline in imports and the overall trade deficit. While the contraction in the deficit at face value suggests trade could significantly add to gross domestic product in the second quarter, economists say some of the boost could be offset by low inventories. Inventory accumulation increased at a rate of $163.0 billion in the first quarter. The economy contracted at a 0.2% annualized rate in the January-March period, the first GDP decline in three years. It grew at a 2.4% pace in the fourth quarter. Sales at wholesalers edged up 0.1% in April after jumping 0.8% in March. At April's sales pace it would take wholesalers 1.30 months to clear shelves, unchanged from March.
Scotsman
3 hours ago
- Scotsman
The BaByliss Rose Gold Hair Straighteners are on sale with 67% off
Get 67% off these stunning BaByliss Hair Straighteners limited time deal - customers say are 'as good as ghd' | Amazon This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement. The BaByliss Rose Gold Hair Straighteners are a must-have essential for beauty lovers. Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... If you're looking for salon-quality hair at home without spending a fortune then the BaByliss Rose Gold Hair Straighteners £29.99 are exactly what you need. Combining sleek aesthetics with advanced technology, these straighteners offer premium features for a fraction of the price. You can save a huge 67% off the original £90 price right now from Amazon but this is a limited-time deal. BaByliss Rose Gold Hair Straighteners BaByliss Rose Gold Hair Straighteners | Amazon Customers are loving the Babyliss straighteners with over 77% giving them a five star review. One person wrote: 'Excellent on my hair, just as good as ghd.' Whilst another person explained : 'The hair straightener gets hot quickly, has a long cable which gives u enough mobility,' however, they added 'only minus I personally do not love the rose pink colour.' Crafted in a stunning rose gold finish, these straighteners are as stylish as they are effective. The ceramic plates glide through your hair without pulling and they have three customisable heat settings (180°C, 200°C, and 235°C). The Advanced Ceramics heating system ensures the straighteners heat up in just 15 seconds, staying hot and consistent throughout your styling. This ultra-fast readiness makes it ideal for busy mornings or last-minute touch-ups. The built-in multi-voltage capability means you can use these straighteners virtually anywhere in the world. The straightening irons also come with a matching rose coloured heat-proof mat and for safety they automatically turn off after one hour. So you have peace of mind and never worrying about whether or not you turned them off before leaving the house. The BaByliss Rose Gold Hair Straighteners are more than just a pair of pretty pink irons. With salon-quality features, quick heat-up time, travel functionality, and a design that turns heads, this tool is an absolute must-have. And at just £29.99, it's a beauty steal you don't want to miss. 💪 Women 55+ are leading the way in healthy weight loss A major UK study shows that women over 55 are seeing the best results from weight loss jabs like Wegovy and Mounjaro – and it's not just the medication that's working. According to research from Voy and Imperial College London, older women who track their weight and attend coaching sessions lose 53% more weight than those relying on jabs alone. ✨ Voy offers a personalised, medically guided plan combining prescription support with coaching and digital habit-building tools. Learn more and check your eligibility here. Natalie Dixon is NationalWorld's Lifestyle reporter . If you liked this article and want to read more about fashion, beauty and lifestyle you can follow Natalie Dixon on X here . You can also Get the best style and fashion news with Natalie Dixon in Tuesday's NationalWorld newsletter - sign up now
Reuters
3 hours ago
- Reuters
Brazil inflation estimated to have edged down in May
June 9 (Reuters) - Brazil's inflation is estimated to have edged down in May as a persistent rise in food and beverage prices took a break, a Reuters poll found. Food inflation has begun to cool due to a large supply of foodstuffs from a good crop and rising cattle farming, coupled with the commercial impact of a bird flu outbreak leading to a glut on the domestic market. Official data to be published on Tuesday will likely show inflation ran at a 0.33% monthly rate and 5.40% in the 12 months to May, according to median estimates of 19 economists polled June 4-9. This would mark a decline from April's 0.43% monthly rate and 5.53% for the 12-month reading, the fastest annual clip since February 2023. UBS analysts noted May's trajectory was driven by an energy price hike, while "(monthly) food inflation is likely to print close to zero, as it reaches its low season of May-August." "Fresh food may already show prices falling, contributing 4 basis points to the downside", the bank's economists added. Bi-weekly figures last month reflected price falls in categories like grains, fruits and vegetables as well as low increases in flour and milk. Also, chicken prices dropped around 7% since the start of the bird-flu event, Brazil's Agriculture minister said last week. Exporters redirected poultry products to domestic consumers after a slew of international bans. Still, the 12-month inflation gauge is set to come in for the 8th consecutive month above the government's target of 3% plus/minus 1.5 percentage points. Beyond food and energy trends, services have been a key factor behind Brazil's sticky inflation recently, with a resilient job market pushing up the sector's costs. However, core services inflation probably moderated to a 0.35% monthly rate in May from 0.61% in April, Barclays said in a report. This would support growing views the economy is slowing down, a process expected to become clearer in the second half of the year. The nascent deceleration is the result of a monetary tightening campaign that last month brought up Brazil's benchmark interest rate to 14.75%, a near-two decade high. The central bank is maintaining a data-driven approach for its June rate-setting meeting, without committing to a specific policy path, governor Gabriel Galipolo said on Saturday.
